Dr. Farzad Moazed, MD

Dr. Moazed practices at Alameda Health System - Highland Hospital in Oakland, California, part of Alameda County.

Dr. Moazed's NPI, 1063676674, was assigned on July 12, 2008. Dr. Moazed graduated from Feinberg School of Medicine in 2008. Dr. Moazed holds California license A119683.

Dr. Moazed's primary practice is Alameda Health System - Highland Hospital, at 1411 East 31st Street, Oakland, CA 94602 in Alameda County. The practice phone is (510) 437-4800.

Dr. Moazed's primary practice is Alameda Health System - Highland Hospital in Oakland, California, part of Alameda County. Dr. Moazed is also affiliated with Alameda Hospital. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Moazed to 1 more community health center, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Moazed's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moazed practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Moazed's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Moazed is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Moazed's licenses on file in 2 states: California and Illinois.

CMS data shows 216 Medicare services from Dr. Moazed across 7 procedure codes in 2024, for 114 Medicare patients. Medicare paid $19,717 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Moazed in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 62% have high cholesterol. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moazed's median patient age at 63, with 47% women.

In 2024, Dr. Moazed wrote 205 Medicare Part D claims for 42 patients. 61% of them were for generic drugs. CMS names the drug for 129 of them, across 6 drugs with 11 or more claims each, at $23,734 in total drug cost. In 2023, CMS named 107 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Moazed for performance year 2024, reported as part of a group. Dr. Moazed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Moazed, published from 2007 to 2021. 2018 was the busiest year, with 3. The most frequent topics are Respiratory Distress Syndrome, Critical Illness and Internal Medicine. Dr. Moazed has published most often in Am J Respir Crit Care Med. Dr. Moazed's most frequent co-authors are Carolyn Suzanne Calfee, MD, Carolyn Marie Hendrickson, MD and Charles Regis Langelier, MD, PhD.

CMS Open Payments shows 1 general payment to Dr. Moazed from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Organon LLC paid the most, $127.

Dr. Moazed graduated from Feinberg School of Medicine in 2008.

Dr. Moazed is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.